If these goals were achieved, the initial stage of the development of a bivalent vaccine against rabies and brucellosis would be accomplished.
En caso de alcanzar estas metas, se habrá cumplido con la primera etapa para desarrollar una vacuna bivalente contra brucelosis y rabia.